Objectives:We examined the existence of hCG/LH receptors and associated GTP-binding (G) proteins in membrane fractions of nonpregnant human endometrium and investigated whether their expression is affected, in vivo, by estrogen and progesterone replacement therapy.
Methods:A pool of normal endometrial biopsy specimens (n = 5) was initially used to characterize receptors and G proteins. Subsequently, biopsy specimens (n = 22) were obtained from 11 patients undergoing evaluation cycles of hormone replacement therapy (HRT). From each patient, two specimens were collected on successive cycle days: on day 0 (last day of estrogen) and on either day 3, 6, or 9 of progesterone supplementation. Both hCG/LH receptor and G proteins were determined in membrane (10,000 × g) fractions by immunoblot analysis using specific polyclonal antibodies against synthetic fragments of hCG/LH receptor and against G proteins. Membrane fractions from rat brain and rat corpus luteum were used as controls. Proteins were loaded on the gel under reducing conditions.
Results:The receptor antibody immunoreacted with a protein of approximately 68 kd in endometrial membranes. A similar protein was detected in rat corpus luteum. The G-protein antibodies detected Gsα, Gi3α, Gi1α/Gi2α, and common beta subunits in endometrial membranes with a molecular weight of 48-42 kd, 41 kd, 40 kd, and 37 kd, respectively. Analysis of membranes obtained during HRT indicated that levels of hCG/LH receptors remained fairly constant throughout the cycle days (days 0, 3, 6, and 9). Similar results were observed for Gi1α/Gi2α and Gi3α. In great contrast, Gsα was low at day 0 but increased with the administration of progesterone (days 3, 6, and 9).
Conclusions:Human endometrium contains both membrane-bound hCG/LH receptors and associated G proteins. During HRT, progesterone ssupplementation to estrogen therapy enhances the expression of Gsα protein subunit, but not hCG/LH receptors.
1. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor...4 years later. Endocr Rev1993;14:324-347.
2.
2. Reshef E, Lei ZM, Rao ChV, Pridham DD, Chegini N, Luborky JL. The presence of gonadotropin receptors in non pregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab1990;70:421-430.
3.
3. Lei ZM, Toth P, Rao ChV, Pridham D. Novel coexpression of human chorionic gonadotropin (HCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endcrinol Metab1993;77:863-872.
4.
4. Rao ChV, Li X, Toth P, Lei ZM, Cook VD. Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol Metab1993;77:1706-1714.
5.
5. Lei ZM, Rao ChV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology1993;132:2262-2270.
6.
6. Kornyei JL, Lei ZM, Rao ChV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod1993;49:1149-1157.
7.
7. Lei ZM, Reshef E, Rao ChV. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab1992;75:651-659.
8.
8. Lei ZM, Rao ChV, Lincoln SR, Ackerman DM. Increased expression of human chorionic gonadotropin/human leutinizing hormone receptors in adenomyosis. J Clin Endocrinol Metab1993;76:763-768.
9.
9. Lei ZM, Rao ChV, Satyaswaroop PG, Day TG. The expression of hCG/LH receptors in human endometrial carcinomas (abstract 209). 39th Annual Meeting of the Society for Gynecologic Investigation, March 18-21, 1992, San Antonio, Texas.
10.
10. Lei ZM, Rao ChV, Ackerman DM, Day TG. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms. J Clin Endocrinol Metab2992;74:1236-1241.
11.
11. McClure N, Hedly DL, Rogers PAW, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet1994;344:235-236.
12.
12. Toth P, Li X, Rao ChV, et al. Expression of functional human chorionic gonadotropin/human luterinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab1994;79:307-315.
13.
13. Khan-Dawood F, Dawood Y. Chorionic gonadotropin receptors and immunoreactive chorionic gonadotropin in implantation of the rabbit blastocyst. Am J Obstet Gynecol1984;148:359-365.
14.
14. Bonnamy PJ, Benhaim A, Leymaire P. Uterine luteinizing hormone/human chorionic gonadotropin-binding sites in the early pregnant rat uterus: Evidence for total occupancy in the periimplantation period. Endocrinology1993;132:1240-1246.
15.
15. Spiegel AM, Shenker A, Weinstein LS. Receptor-effector coupling by G proteins: Implications for normal and abnormal signal transduction. Endocr Rev1992;13:536-563.
16.
16. Balmaceda JP, Bernardini L, Ciuffardi I, et al. Oocyte donation in humans: A model to study the effect of age on embryo implantation rate. Hum Reprod1994;9:2160-2163.
17.
17. Asch RH. Egg and embryo donation: Implantation aspects in infertility. In: Templeton AA, Drife JO, eds. Infertility. London: Springer-Verlag, 1992:279-289.
18.
18. Rojas FJ, Asch RH. Properties of gonadotropin-stimulable adenylyl cyclase of the human corpus luteum: Regulation of Hormonal responsiveness by guanyl nucleotide an magnesium ion. J Clin Endocrinol Metab1984;59:219-227.
19.
19. Laemmli UK. Cleavage of structural proteins during hte assembly of the head of bacteriophage T4. Nature1970;227:680-685.
20.
20. Roche PC, Ryan R. Purification, characterization, and amino-terminal sequence of rat ovarian receptor for luteinizing hormone/human choriogonadotropin. J Biol Chem1989;264:4636-4641.
21.
21. Rosemblit N, Ascoli M, Segaloff DL. Characterization of an antiserum to the rat luteal luteinizing hormone/chorionic gonadotropin receptor. Endocrinology1988;123:2284-2290.
22.
22. Dattatreyamurty B, Rathnam P, Saxena BB. Isolation of the luteinizing hormone-chorionic gonadotropin receptor in high yield from bovine corpora lutea. J Biol Chem1983;258:3140-3158.
23.
23. Vuhai-luuthi MT, Jolivet A, Jallal B, et al. Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor. Endocrinology1990;127:2090-2098.
24.
24. Tanfin Z, Goureau O, Milligan G, Harbon S. Characterization of G proteins in rat myometrium. FEBS Lett1991;278:4-8.
25.
25. Dym M, Lamsam-Casalotti S, Jia M-C, Kleinman HK, Papadopoulos V. Basement membrane increases G-protein levels and follicle-stimulating hormone responsiveness of Sertoli cell adenylyl cyclase activity. Endcrinology1991;128:1167-1176.
26.
26. Bernardini L, Moretti-Rojas I, Rojas FJ, Balmaceda JP. Expression of adenylyl cyclase activity in human endometrium during hormone replacement therapy and controlled ovarian hyperstimulation (abstract P023). 42nd Annual Meeting of the Pacific Coast Fertility Society, April 20-24, 1994, Indian Wells, California.
27.
27. Cockroft S, Gomperts BD. Role of Guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature1985;314:534-535.
28.
28. Jelsema CL, Axelrod J. Stimulation of phospholipase A2 activity in bovine rod outer segments by the beta gamma subunits of transducin and its inhibition by the alpha sub-unit. Proc Natl Acad Sci USA1987;84:3623-3627.
29.
29. Raw RE, Silvia WJ. Activity of phospholipase C and release of prostaglandin F2 alpha by endometrial tissue from ovariectomized ewes receiving progesterone and estradiol. Biol Reprod1991;44:404-412.
30.
30. Frank GR, Brar AK, Cedars MI, Handwerger S. Prostaglandin E2 enhances human endometrial stromal cell differentiation. Endocrinology1994;134:258-253.
31.
31. Worley PF, Baraban JM, Van Dop C, Neer EJ, Synder SM. G0, a quanine nucleotide-binding protein: Immunohistochemical localization in rat brain resembles distribution of second messenger systems. Proc Natl Acad Sci USA1986;84:456-464.
